108 related articles for article (PubMed ID: 32795829)
1. Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy.
Montagna E; Cancello G; Pagan E; Bagnardi V; Munzone E; Dellapasqua S; Viale G; Mazzarol G; Veronesi P; Galimberti V; Santomauro G; Colleoni M
Breast; 2020 Oct; 53():138-142. PubMed ID: 32795829
[TBL] [Abstract][Full Text] [Related]
2. Triple-negative apocrine carcinoma: A rare pathologic subtype with a better prognosis than other triple-negative breast cancers.
Arciero CA; Diehl AH; Liu Y; Sun Q; Gillespie T; Li X; Subhedar P
J Surg Oncol; 2020 Nov; 122(6):1232-1239. PubMed ID: 32668059
[TBL] [Abstract][Full Text] [Related]
3. Avoidance and Period-Shortening of Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer in Stages I and II: Importance of Ki-67 Labeling Index and the Recognition of Apocrine-Type Lesions.
Kubouchi K; Shimada K; Yokoe T; Tsutsumi Y
Technol Cancer Res Treat; 2020; 19():1533033820943246. PubMed ID: 32677589
[TBL] [Abstract][Full Text] [Related]
4. Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial.
Wang X; Wang SS; Huang H; Cai L; Zhao L; Peng RJ; Lin Y; Tang J; Zeng J; Zhang LH; Ke YL; Wang XM; Liu XM; Chen QJ; Zhang AQ; Xu F; Bi XW; Huang JJ; Li JB; Pang DM; Xue C; Shi YX; He ZY; Lin HX; An X; Xia W; Cao Y; Guo Y; Su YH; Hua X; Wang XY; Hong RX; Jiang KK; Song CG; Huang ZZ; Shi W; Zhong YY; Yuan ZY;
JAMA; 2021 Jan; 325(1):50-58. PubMed ID: 33300950
[TBL] [Abstract][Full Text] [Related]
5. Metaplastic breast cancer: Prognostic and therapeutic considerations.
Corso G; Frassoni S; Girardi A; De Camilli E; Montagna E; Intra M; Bottiglieri L; Margherita De Scalzi A; Fanianos DM; Magnoni F; Invento A; Toesca A; Conforti F; Bagnardi V; Viale G; Colleoni MA; Veronesi P
J Surg Oncol; 2021 Jan; 123(1):61-70. PubMed ID: 33047318
[TBL] [Abstract][Full Text] [Related]
6. Mixed Invasive Apocrine Papillary/Micropapillary Carcinoma of the Breast: Another Brick in the Triple-Negative Wall.
Cima L; Mirabassi N; Sartori C; Carbone FG; Morelli L; Cserni G; Barbareschi M
Int J Surg Pathol; 2021 Jun; 29(4):420-426. PubMed ID: 32909476
[TBL] [Abstract][Full Text] [Related]
7. Association of sonographic features and molecular subtypes in predicting breast cancer disease outcomes.
Wang H; Yao J; Zhu Y; Zhan W; Chen X; Shen K
Cancer Med; 2020 Sep; 9(17):6173-6185. PubMed ID: 32657039
[TBL] [Abstract][Full Text] [Related]
8. Apocrine Breast Cancer: Unique Features of a Predominantly Triple-Negative Breast Cancer.
Saridakis A; Berger ER; Harigopal M; Park T; Horowitz N; Le Blanc J; Zanieski G; Chagpar A; Greenup R; Golshan M; Lannin DR
Ann Surg Oncol; 2021 Oct; 28(10):5610-5616. PubMed ID: 34426884
[TBL] [Abstract][Full Text] [Related]
9. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
Zhao H
Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
[TBL] [Abstract][Full Text] [Related]
10. Risk and prognostic factors of breast cancer with liver metastases.
Ji L; Cheng L; Zhu X; Gao Y; Fan L; Wang Z
BMC Cancer; 2021 Mar; 21(1):238. PubMed ID: 33676449
[TBL] [Abstract][Full Text] [Related]
11. Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review.
Trapani D; Giugliano F; Uliano J; Zia VAA; Marra A; Viale G; Ferraro E; Esposito A; Criscitiello C; D'amico P; Curigliano G
Breast Cancer Res Treat; 2021 Jun; 187(2):323-337. PubMed ID: 34043122
[TBL] [Abstract][Full Text] [Related]
12. Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy.
Hu T; Liu Y; Wu J; Hu XL; Zhao G; Liang B; Wang S; Long M
J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329934
[TBL] [Abstract][Full Text] [Related]
13. Disease Behavior and Treatment Response of Special Histological Types of Triple-Negative Breast Cancer.
Bonadio RC; Costa FA; Mendes SV; Araujo BJ; Nader-Marta G; Pinto PBC; Batista DN; Testa L; Ferrari MS
Clin Breast Cancer; 2022 Dec; 22(8):e892-e900. PubMed ID: 36130851
[TBL] [Abstract][Full Text] [Related]
14. Determinants of Prognosis in Triple-Negative Breast Cancer: Report from a Large Breast Cancer Registry.
Tahmasebi S; Almayali AMJ; Arasteh P; Akrami M; Zangouri V; Arasteh P; Hosseini SM; Salehi Nobandegani A; Asgari A; Sadeghi E; Zahiri L; Talei A
Arch Iran Med; 2021 Apr; 24(4):280-288. PubMed ID: 34196187
[TBL] [Abstract][Full Text] [Related]
15. Synchronous bilateral primary breast apocrine carcinoma and invasive breast cancer: A rare case report.
Lv H; Kong J; Liu W; Song C
Asian J Surg; 2024 Jun; 47(6):2691-2692. PubMed ID: 38538391
[No Abstract] [Full Text] [Related]
16. Operable breast cancer: How not to worsen the prognosis, especially in triple negative and stage II tumors.
de Araújo RA; Cordero da Luz FA; da Costa Marinho E; Mendes TR; Nascimento CP; Ribeiro Delfino PF; Antonioli RM; Ruas AC; Alves AR; Araújo BJ; de Paula Machado JP; Guedes Pereira TO; França do Espírito Santo M; Barbosa Silva MJ
Surg Oncol; 2021 Sep; 38():101596. PubMed ID: 34015750
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic utility of EZH2 H-score and Ki-67 index in non-invasive breast apocrine lesions.
Vougiouklakis T; Belovarac BJ; Lytle A; Chiriboga L; Ozerdem U
Pathol Res Pract; 2020 Sep; 216(9):153041. PubMed ID: 32825929
[TBL] [Abstract][Full Text] [Related]
18. Retrospective Study of Treatment Patterns and Natural History of Patients with T1a/b N0 Triple-Negative Breast Cancers: A Single-Institution Experience.
Liu L; Lewis N; Sun W; Whiting J; Hoover S; Costa RLB
Oncology; 2023; 101(12):765-772. PubMed ID: 37527637
[TBL] [Abstract][Full Text] [Related]
19. All Benign and Malignant Apocrine Breast Lesions Over-Express Claudin 1 and 3 and Are Negative for Claudin 4.
Shousha S; Anscombe O; McFarlane T
Pathol Oncol Res; 2020 Apr; 26(2):1073-1078. PubMed ID: 31044387
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy is of prognostic significance to metaplastic breast cancer.
Zhang M; Yuan J; Wang M; Zhang M; Chen H
Sci Rep; 2024 Jan; 14(1):1210. PubMed ID: 38216630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]